CRISIL assigns IPO grade of ‘3/5’ to Advanced Enzyme Technologies

06 Sep 2013 Evaluate

Credit rating agency, CRISIL has assigned an IPO grade of ‘3/5’ to the proposed IPO of Advanced Enzyme Technologies (AETL). This grade indicates that the fundamentals of the IPO are ‘average’ relative to the other listed equity securities in India.

Earlier in April, the company filed a draft red herring prospectus (DRHP) with SEBI for a public issue of Rs 200 crore. The equity shares issued through this DRHP are proposed to be listed on BSE and NSE. Moreover, ICICI Securities, SBI Capital Markets are the book running lead manager and Link Intime India Private is a registrar to the issue.

The company is one of the largest Indian enzyme company engaged in the research & development, manufacturing and marketing of more than 400 proprietary enzyme products developed from 55 enzymes operating in two primary business verticals namely Healthcare & Nutrition and Bio-Processing. Advanced Enzyme Technologies offer these products to their global clientele of more than 700 customers spanning presence across 45 countries worldwide.

© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.